ADMA Biologics Inc vs Eaton Corporation plc — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Eaton Corporation plc trades at $467.8 (market cap $172.82B). The key difference: Eaton Corporation plc is far larger — about 77.8× ADMA Biologics Inc's market cap, and Eaton Corporation plc pays a 0.99% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | ETN | |
|---|---|---|
Market Cap | $2.22B | $172.82B |
Sector | Health | Technology |
52-Week High | $20.38 | $459.29 |
52-Week Low | $7.60 | $315.82 |
Enterprise Value | $2.29B | $193.45B |
Dividend Yield | — | 0.99% |
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.87, up 1.23% today, with a bullish technical signal supported by moving averages. The company reported strong 2025 fundamentals, including $510.17M revenue, 32.98% net income margin, and robust profitability metrics like 41.9% ROE. However, recent Q1 and Q2 2026 earnings missed expectations, and the stock faces significant negative sentiment due to multiple class-action lawsuits alleging securities fraud, with deadlines in August 2026.
The outlook is mixed: strong fundamentals and an 88.89% analyst buy rating support upside, but legal overhangs and earnings misses pose near-term risks. Investors should weigh solid financial health against potential volatility from litigation outcomes and execution consistency.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →